iTRAQ‐coupled 2‐D LC‐MS/MS analysis of protein profile associated with HBV‐modulated DNA methylation
Authors:
- 7 August 2009
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 9 (15) , 3856-3868
Abstract
The development of hepatocellular carcinoma (HCC) is believed to be associated with multiple risk factors, including the infection of hepatitis B virus (HBV). Based on the analysis of individual genes, evidence has indicated the association between HCC and HBV and has also been expanded to epigenetic regulation, with an involvement of HBV in the DNA methylation of the promoter of cellular target genes leading to changes in their expression. Proteomic study has been widely used to map a comprehensive protein profile, which in turn could provide a better understanding of underlying mechanisms of disease onset. In the present study, we performed a proteomic profiling by using iTRAQ‐coupled 2‐D LC/MS‐MS analysis to identify cellular genes down‐regulated in HBV‐producing HepG2.2.15 cells compared with HepG2 cells. A total of 15 proteins including S100A6 and Annexin A2 were identified by our approach. The significance of these cellular proteins as target of HBV‐mediated epigenetic regulation was supported by our validation assays, including their reactivation in cells treated with 5‐aza‐2′‐deoxycytidine (a DNA methyltransferase inhibitor) by real‐time RT‐PCR and Western blot analysis, as well as the DNA methylation status analysis by bisulfite genome sequencing. Our approach provides a comprehensive analysis of cellular target proteins to HBV‐mediated epigenetic regulation and further analysis should facilitate a better understanding of its involvement in HCC development.Keywords
Funding Information
- Ministry of Education, Singapore (RG42/05)
- Nanyang Technological University
- Singapore Millennium Foundation Scholarship
This publication has 38 references indexed in Scilit:
- Colon-Derived Liver Metastasis, Colorectal Carcinoma, and Hepatocellular Carcinoma Can Be Discriminated by the Ca2+-Binding Proteins S100A6 and S100A11PLOS ONE, 2008
- Protein profile in neuroblastoma cells incubated with S ‐ and R ‐enantiomers of ibuprofen by iTRAQ‐coupled 2‐D LC‐MS/MS analysis: Possible action of induced proteins on Alzheimer's diseaseProteomics, 2008
- Identification of molecular markers for the oncogenic differentiation of hepatocellular carcinomaExperimental & Molecular Medicine, 2007
- Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastomaBritish Journal of Cancer, 2007
- Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging ReagentsMolecular & Cellular Proteomics, 2004
- N-Terminal Isotope Tagging Strategy for Quantitative Proteomics: Results-Driven Analysis of Protein Abundance ChangesAnalytical Chemistry, 2004
- Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migrationOncogene, 2003
- S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinomaHepatology Research, 2002
- Expression of Integrated Hepatitis B Virus X Variants in Human Hepatocellular Carcinomas and Its SignificanceBiochemical and Biophysical Research Communications, 2000
- The S100 family of EF-hand calcium-binding proteins: functions and pathologyTrends in Biochemical Sciences, 1996